ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...
Päätekijä: | R.T. Saygitov |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
"Paediatrician" Publishers LLC
2008-08-01
|
Sarja: | Вопросы современной педиатрии |
Linkit: | https://vsp.spr-journal.ru/jour/article/view/1441 |
Samankaltaisia teoksia
-
ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
Tekijä: R.T. Saygitov
Julkaistu: (2008-01-01) -
Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
Tekijä: Cardile S, et al.
Julkaistu: (2012-02-01) -
Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
Tekijä: Yu. V. Yevsyutina
Julkaistu: (2018-08-01) -
Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
Tekijä: Gold Benjamin D, et al.
Julkaistu: (2009-11-01) -
Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
Tekijä: Roy C Orlando, et al.
Julkaistu: (2010-09-01)